BioSpace News Archive

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Tenaya management will participate in the Piper Sandler 34th Annual Healthcare Conference, taking place in New York, NY, from November 29th to December 1st.

According to Nova one advisor, the global 3D Printed Drugs market size is expected to hit around USD 319.74 million by 2030 from valued at USD 102.9 million in 2021 and growing at a CAGR of 16.32% from 2022 to 2030.

According to Nova one advisor, the global Biomaterials market size is expected to hit around USD 488.9 billion by 2030 from valued at USD 135.8 billion in 2021 and growing at a CAGR of 15.8% from 2022 to 2030.